Literature DB >> 17351642

Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes.

Carolina Jancic1, Ariel Savina, Christina Wasmeier, Tanya Tolmachova, Jamel El-Benna, Pham My-Chan Dang, Steve Pascolo, Maire-Anne Gougerot-Pocidalo, Graça Raposo, Miguel C Seabra, Sebastian Amigorena.   

Abstract

To prevent excessive degradation of internalized antigens, which could destroy the peptides recognized by T lymphocytes, dendritic cells have developed several strategies that limit proteolytic activity in phagosomes. The recruitment of the NADPH oxidase NOX2 prevents acidification of phagosomes, limiting antigen degradation. Here, we show that dendritic cells derived from Rab27a-deficient ashen mice show increased phagosome acidification and antigen degradation, causing a defect in antigen cross-presentation. Enhanced acidification results from a delay in the recruitment to phagosomes of a subset of lysosome-related organelles containing the membrane subunits of NOX2. The Rab27a-dependent recruitment of these "inhibitory lysosome-related organelles" to phagosomes continuously limits acidification and degradation of ingested particles in dendritic cells, thus promoting antigen cross-presentation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351642     DOI: 10.1038/ncb1552

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  132 in total

Review 1.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 2.  Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells.

Authors:  Ryan G Gaudet; Clinton J Bradfield; John D MacMicking
Journal:  Microbiol Spectr       Date:  2016-12

3.  In vivo requirement for Atg5 in antigen presentation by dendritic cells.

Authors:  Heung Kyu Lee; Lisa M Mattei; Benjamin E Steinberg; Philipp Alberts; Yun Hee Lee; Alexander Chervonsky; Noboru Mizushima; Sergio Grinstein; Akiko Iwasaki
Journal:  Immunity       Date:  2010-02-18       Impact factor: 31.745

Review 4.  Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.

Authors:  Marianne Boes; Arie J Stoppelenburg; Fenna C M Sillé
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

5.  Recruitment of Rab27a to phagosomes controls microbial antigen cross-presentation by dendritic cells.

Authors:  Seong Hyun Kim; Annelies Visser; Carin Cruijsen; Adrianus W M van der Velden; Marianne Boes
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

6.  Exophilin-5 regulates allergic airway inflammation by controlling IL-33-mediated Th2 responses.

Authors:  Katsuhide Okunishi; Hao Wang; Maho Suzukawa; Ray Ishizaki; Eri Kobayashi; Miho Kihara; Takaya Abe; Jun-Ichi Miyazaki; Masafumi Horie; Akira Saito; Hirohisa Saito; Susumu Nakae; Tetsuro Izumi
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 7.  Phagosome maturation: going through the acid test.

Authors:  Jason M Kinchen; Kodi S Ravichandran
Journal:  Nat Rev Mol Cell Biol       Date:  2008-10       Impact factor: 94.444

Review 8.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

Review 9.  Endogenous and tumour-derived microRNAs regulate cross-presentation in dendritic cells and consequently cytotoxic T cell function.

Authors:  Siambi Kikete; Xiaoqian Chu; Li Wang; Yuhong Bian
Journal:  Cytotechnology       Date:  2016-05-18       Impact factor: 2.058

10.  A catalytically inactive mutant of the deubiquitylase YOD-1 enhances antigen cross-presentation.

Authors:  Sharvan Sehrawat; Paul-Albert Koenig; Oktay Kirak; Christian Schlieker; Manuel Fankhauser; Hidde L Ploegh
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.